Comparison

KRM-III European Partner

Manufacturer MedChem Express
Category
Type Biochemicals
Specific against other
Amount 10mM/1mL
Quantity options 100 mg 10mM/1mL 10 mg 25 mg 50 mg 5 mg
Item no. HY-136427-10mM
Targets Others
CASRN 79220-94-3
eClass 6.1 32160405
eClass 9.0 32160490
Available
Purity 98.08
Product Description
KRM-III is a potent and orally active T-cell antigen receptor (TCR) inhibitor. KRM-III inhibits TCR- and phorbol myristate acetate/ionomycin-induced activation of nuclear factor of activated T cells (NFAT) and T-cell proliferation with an IC50 of ~5 μM. Anti-inflammatory activity[1].
StorageTemperature
-20°C, 3 years; 4°C, 2 years (Powder)
Shipping
Room Temperature
Manufacturers Applications
COVID-19-immunoregulation
MolecularWeight
252.33
Clinical_Information
No Development Reported
Manufacturers Research Area
Inflammation/Immunology
Solubility
DMSO : 100 mg/mL (ultrasonic)
Manufacturers Target
Nuclear Factor of activated T Cells (NFAT)
Pathway
Immunology/Inflammation

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 10mM/1mL
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
Recently viewed
 
Close